Scarring Alopecia: Diagnosis and Treatment

ISHRS 2025 CME Webinar

Scarring Alopecia: Diagnosis and Treatment

Wednesday, December 10, 2025
9:00 AM to 11:30 AM CST
Duration: 2 hours 30 minutes
(Time Zone Conversion)

Registration Fees Per Webinar

Physician Attendees of ISHRS 2024 Denver World Congress$0.00 USD
ISHRS Physician Member
Non-Attendees of ISHRS 2024 Denver World Congress
$75.00 USD
ISHRS Physician Pending-Member
Non-Attendees of ISHRS 2024 Denver World Congress
$100.00 USD
Physician Non-Member
Non-Attendee of ISHRS 2024 Denver World Congress
$125.00 USD

Moderators

Moderator: Vikram Jayaprakash, BM, FISHRS | Australia
Co-Moderator: Bruno Pinto Gonçalves, MD, MSc | Portugal

Program Description

This 2.5-hour live webinar, “Scarring Alopecia: Diagnosis and Treatment,” will provide a comprehensive and clinically relevant overview of scarring alopecias, a complex group of disorders characterized by irreversible hair loss due to permanent follicular destruction. Through expert lectures, case-based discussions, and interactive Q&A, participants will gain updated knowledge on the classification, diagnostic approach, trichoscopic patterns, biopsy interpretation, medical management, and surgical considerations in patients with scarring alopecia.

The program is designed to bridge critical gaps in clinical practice by enhancing the diagnostic accuracy of hair restoration physicians and improving their ability to implement evidence-based treatment strategies. Faculty experts will present the latest scientific advances, practical management algorithms, and real-world clinical considerations to empower physicians in optimizing patient outcomes.

Professional Practice Gap

Scarring alopecias represent a diagnostically challenging and often under-recognized category of hair loss disorders, frequently misdiagnosed as non-scarring alopecias such as androgenetic alopecia, telogen effluvium, Alopecia Areata . Many physicians lack structured training in differentiating the subtle clinical and trichoscopic signs of early scarring alopecia, leading to delayed diagnosis, inappropriate treatment, and irreversible permanent hair loss for patients.

  • Additionally, there is wide variability among practitioners in:
  • Recognizing early inflammatory activity
  • Selecting appropriate biopsy sites
  • Interpreting pathology reports
  • Implementing evidence-based systemic therapies
  • Determining when (and if) surgical restoration is safe or contraindicated

These practice gaps result in significant patient harm, inconsistent clinical outcomes, and lost opportunities for early intervention.

Educational Need

To improve patient care and clinical outcomes, hair restoration surgeons and dermatologic physicians require focused continuing medical education on the accurate diagnosis and optimal management of scarring alopecia. The educational needs include:

  • Knowledge Need: Updated information on pathophysiology, classification, and diagnostic criteria for primary and secondary scarring alopecias.
  • Competence Need: Enhanced ability to differentiate scarring from non-scarring alopecias using clinical signs, trichoscopy, and biopsy.
  • Performance Need: Skills to implement evidence-based treatment protocols (medical and surgical), monitor disease activity, manage long-term follow-up, and understand the risks and limitations of hair transplantation in these conditions.

Addressing these needs is critical to preventing irreversible hair loss, minimizing complications, and elevating the standard of care in global hair restoration practice.

Learning Objectives

By the end of this webinar, participants will be able to:

  • Differentiate between primary and secondary scarring alopecias based on clinical presentation, disease course, and etiopathogenesis.
  • Identify the key diagnostic features of scarring alopecia using clinical examination, trichoscopy, and appropriate biopsy techniques.
  • Interpret pathology findings relevant to the various subtypes of scarring alopecia to improve diagnostic accuracy.
  • Implement evidence-based medical treatments, including anti-inflammatory, immunomodulatory, and antifibrotic therapies, tailored to disease subtype and severity.
  • Assess disease activity and determine when hair transplantation may be safe, contraindicated, or require modifications in surgical approach.
  • Develop comprehensive management plans incorporating long-term monitoring, patient counselling, and multidisciplinary care where necessary.

Target Audience and Prerequisites

This webinar is taught at the physician level. It is open to all levels and geared toward advanced hair restoration surgeons.

References

TBA

CME Information

Continuing Medical Education (CME) Credit Statement

The International Society of Hair Restoration Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The International Society of Hair Restoration Surgery designates this Other Activity (blended synchronous and enduring) for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To receive CME credit and a CME certificate, participants must participate in the activity, complete the evaluation survey and the CME Claim Form by January 12, 2026.

Format

Internet/online, via computer or mobile device. 

Official Language

The official language of the webinar is English. Simultaneous interpretation is not provided for this webinar.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the ISHRS must ensure that anyone in a position to control the content of the educational activity (planners/ speakers/authors/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

  • Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
  • Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
  • Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ISHRS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Disclosures of Relevant Financial Relationships of Planners, Faculty, and Others

The following individuals have no relevant financial relationships with ineligible companies to disclose:

Planners

  • Marco Barusco, MD, FISHRS – Planner
  • Victoria Ceh, MPA – Planner & Manager
  • Bruno Pinto Goncalves, MD, MSc – Planner & Moderator
  • Aditya K. Gupta, MD, PhD, FISHRS – Planner
  • Robert S. Haber, MD, FISHRS – Planner
  • Rana Irfan, MBBS, FISHRS – Planner
  • Vikram Jayaprakash, BM, FISHRS – Planner & Moderator
  • Marissa LaDue, MPH – Planner & Manager
  • Hafiz Waqar Maqsood, MBBS – Planner
  • Maira Merlotto, MD, MsC – Planner
  • Ratchathorn Panchaprateep, MD, PhD, FISHRS – Planner
  • Farhaad Riyaz, MD – Planner
  • Nicole E. Rogers, MD, FISHRS – Planner
  • Marie A. Schambach, MD, FISHRS | Guatemala – Planner & Faculty
  • Miriam Scheel, MD – Planner
  • Melanie Stancampiano – Planner & Manager

Faculty

  • Thalita Machado Carlesso, MD
  • Uzma Irfan, MBBS

The following individuals have relevant financial relationships:

Planners

None

Faculty

None

All of the relevant financial relationships listed for these individuals have been mitigated.

Commercial Support

None

Off-Label Or Other Non-FDA Approved, Investigational Use

None

Other CME Information

Click for Continuing Medical Education Mission Statement
Learner Bill of Rights
ISHRS Privacy and Confidentiality Policy for Internet CME

Disclaimer

The webinar content has been made available by the ISHRS for educational purposes only. The content is not intended to represent the only, nor necessarily the best, method or procedure appropriate for the medical situations discussed, but rather is intended to present views, statements, and opinions that may be of interest to others. The views expressed herein are those of the individual authors and not necessarily those of the ISHRS. The ISHRS assumes no responsibility or liability in connection with your use or misuse of the webinar content or any materials or techniques described in the content, and it makes no warranty or representation as to the validity or sufficiency of any information provided.

Questions: Learners may contact the ISHRS Headquarters with questions about this CME activity at phone +1-800-444-2737 or +1-630-262-5399, or fax +1-630-262-1520, or email: gro.srhsiobfsctd-18e206@ofni